Cross-sectional Study of Fibromyalgia

A Cross-sectional Study of Fibromyalgia in Beijing

This study is designed to collect data on precipitating factors, diagnosis, morbidity, therapy, quality of life, and symptom severity, etc. informations in patients with fibromyalgia.

Study Overview

• Status: Completed
• Conditions: Fibromyalgia

Detailed Description

Patients fulfilling 1990 ACR criterion for fibromyalgia will be recruited in Fibromyalgia outpatient service which is belonged to the Department of Rheumatism. Except collecting patients' demographic and social characteristic informations, rheumatologist also carry out a comprehensive evaluation including patient current history, current medication use, and tender point examination for a diagnosis or confirmation of fibromyalgia and treatment recommendations. Patients with fibromyalgia will be asked to fill a set of questionnaires to evaluate their quality of life, symptoms severity, quality of sleep and emotion. The study will be conducted in Beijing, China.

• Study Type: Observational
• Enrollment (Actual): 124

Contacts and Locations

Study Locations

• China
  • Beijing
    • Beijing, Beijing, China, 100053
      • Guang'anmen Hospital of China Academy of Chinese Medical Sciences

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 18 years to 80 years (ADULT, OLDER_ADULT)
• Accepts Healthy Volunteers: No
• Genders Eligible for Study: All

• Sampling Method: Probability Sample

Study Population

Patients fulfilling 1990 ACR criterion for fibromyalgia be seen in the Fibromyalgia Outpatient Service which belonged to the Department of Rheumatism, Guang'anmen Hospital, Beijing China.

Description

Inclusion Criteria:

• Age 18 years or older.
• Fulfills the American College of Rheumatology (ACR) 1990 classification criteria for Fibromyalgia.

Exclusion Criteria:

• Don't fulfill any classification criterions for Fibromyalgia.

Study Plan

How is the study designed?

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Time Frame
Fibromyalgia symptoms severity as measured by Fibromyalgia Impact Questionnaire (FIQ)	up to 1 week

Secondary Outcome Measures

Outcome Measure	Time Frame
QOL as measured by Short Form-36 Health Status Questionnaire (SF-36)	up to 1 week
Pain scores as measured by Numerical rating scale (NRS)	up to 1 week
Fatigue scores as measured by Multidimensional Assessment Fatigue (MAF)	up to 1 week
Depression scores as measured by Beck depression inventory (BDI)	up to 1 week
Stress scores as measured by Perceived Stress Scale (PSS)	up to 1 week
Sleep scores as measured by Pittsburgh sleep quality index (PSQI)	up to 1 week

Collaborators and Investigators

• Sponsor: Guang'anmen Hospital of China Academy of Chinese Medical Sciences
• Investigators: Principal Investigator: Juan Jiao, M.D.,PhD, Guang'anmen Hospital of China Academy of Chinese Medical Sciences

Study record dates

Study Major Dates

• Study Start (Actual): April 1, 2015
• Primary Completion (Actual): March 1, 2016
• Study Completion (Actual): March 1, 2018

Study Registration Dates

• First Submitted: May 2, 2015
• First Submitted That Met QC Criteria: May 16, 2015
• First Posted (Estimate): May 20, 2015

Study Record Updates

• Last Update Posted (Actual): November 20, 2018
• Last Update Submitted That Met QC Criteria: November 19, 2018
• Last Verified: November 1, 2018

More Information

Terms related to this study

• Additional Relevant MeSH Terms: Nervous System Diseases; Musculoskeletal Diseases; Rheumatic Diseases; Muscular Diseases; Neuromuscular Diseases; Fibromyalgia; Myofascial Pain Syndromes
• Other Study ID Numbers: 39301